玻璃体黄斑粘连与新血管性年龄相关性黄斑变性的风险
在意大利Sacrocuore医院2008年8月至2015年6月共1067只眼中,渗出性AMD、非渗出性AMD与无AMD对照的玻璃体黄斑粘连(VMA)患病率无显著差异(25.1% vs 24.0% vs 26.8%,P=0.3384);非渗出性AMD中VMA存在与否的新发脉络膜新生血管(CNV)发生率无显著差异(P=0.0966);渗出性AMD眼VMA自发缓解发生率显著低于非渗出性AMD(P=0.0207)。作者认为VMA可能是CNV发展的结果而非原因。
要点
- 渗出性AMD、非渗出性AMD与无AMD对照的VMA患病率无显著差异(P=0.3384)。
- 非渗出性AMD中,VMA存在与否的新发CNV发生率无显著差异(P=0.0966)。
- 渗出性AMD眼VMA自发缓解发生率显著低于非渗出性AMD(P=0.0207)。
核心结论
- AMD眼与年龄匹配对照的VMA患病率无显著差异,VMA存在与否的新发CNV发生率无差异;渗出性AMD眼随时间的VMA自发缓解发生率较低。
- 作者认为VMA可能是CNV发展的结果而非原因。
研究设计与样本
- 意大利Negrar维罗纳Sacrocuore医院的回顾性横断面分析和纵向队列研究。
- 共纳入2008年8月至2015年6月在Sacrocuore医院检查且符合纳入标准的1067只眼。
- 渗出性AMD组:364例患者的403只眼,平均(标准差)年龄77.8(8.0)岁。
- 非渗出性AMD组:298例受试者的350只眼,平均(标准差)年龄78.1(8.2)岁。
- 无AMD体征对照组:214例受试者的314只眼,平均(标准差)年龄74.2(8.2)岁。
主要发现
- VMA存在于渗出性AMD组101只眼(25.1%)、非渗出性AMD组84只眼(24.0%)、无AMD体征组84只眼(26.8%),无统计学差异(P=0.3384)。
- 平均随访分别为25.5、25.9、24.1个月时,VMA自发缓解(RVMA)分别见于渗出性AMD组15只眼(15.3%)、非渗出性AMD组21只眼(28.0%)、无AMD体征组10只眼(24.4%)。
- 渗出性AMD眼RVMA发生率显著低于非渗出性AMD(P=0.0207),与无AMD体征眼相比更低但未达统计学显著(P=0.1013)。
- 非渗出性AMD眼中,新发CNV见于91只眼(30.6%)。
- VMA存在与否的新发CNV发生率无显著差异(P=0.0966)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the prevalence of vitreomacular adhesion (VMA) in consecutive naïve eyes diagnosed with exudative age-related macular degeneration (AMD) in comparison with eyes with nonexudative AMD and age-matched controls, and to evaluate prospectively the incidence of vitreomacular interface changes over time and their influence on choroidal neovascularization (CNV) development. DESIGN: Retrospective cross-sectional analysis and longitudinal cohort study conducted at Sacrocuore Hospital, Negrar, Verona, Italy. PARTICIPANTS: A total of 1067 eyes examined at Sacrocuore Hospital between August 2008 and June 2015 met the inclusion criteria and were evaluated in this study. METHODS: Eyes were classified into 3 groups: 403 eyes of 364 patients (mean [standard deviation; SD] age 77.8 [8.0] years) affected by exudative AMD; 350 eyes of 298 subjects (mean [SD] age 78.1 [8.2] years) with nonexudative AMD; and 314 eyes of 214 subjects (mean [SD] age 74.2 [8.2] years) with no signs of AMD enrolled as the control group. The vitreomacular interface status was evaluated by spectral-domain optical coherence tomography (OCT) and was graded according to the OCT-based International Classification System developed by the International Vitreomacular Traction Study Group by 2 independent masked observers. RESULTS: VMA was present in 101 (25.1%) eyes with exudative AMD, 84 (24.0%) eyes with nonexudative AMD, and 84 (26.8%) eyes with no signs of AMD (no statistical difference was found; P = 0.3384). Spontaneous release of VMA (RVMA) was found in 15 (15.3%) eyes with exudative AMD, 21 (28.0%) eyes with nonexudative AMD, and 10 (24.4%) eyes with no signs of AMD over a mean follow-up of 25.5, 25.9, and 24.1 months, respectively. The incidence of RVMA in exudative AMD eyes was significantly lower compared with nonexudative (P = 0.0207) and lower, but not statistically significant, with respect to eyes with no signs of AMD (P = 0.1013). In eyes with nonexudative AMD, de novo development of CNV occurred in 91 eyes (30.6%). There was no significant difference regarding the rate of CNV development in the presence or absence of VMA (P = 0.0966). CONCLUSIONS: The present study found no significant difference in the prevalence of VMA in eyes affected by AMD compared with age-matched controls and no difference in the rate of de novo CNV development in eyes with or without VMA. Conversely, a lower incidence of RVMA over time was found in eyes affected by exudative AMD. The results of this study suggest that VMA might be a consequence rather than a causative factor in the development of CNV.
引用
- Maggio E, Polito A, Guerriero M, et al. Vitreomacular Adhesion and the Risk of Neovascular Age-Related Macular Degeneration. Ophthalmology. 2017. PMID: 28214102. doi:10.1016/j.ophtha.2017.01.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。